沃森生物(300142.SZ)：公司九价HPV疫苗Ⅲ期临床研究的相关工作在持续开展中

Group 1 - The core viewpoint of the article is that Watson Bio is actively conducting the Phase III clinical research for its nine-valent HPV vaccine and will disclose any substantial and phase-related progress in a timely manner [1]